SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-075319
Filing Date
2024-06-20
Accepted
2024-06-20 08:01:00
Documents
8
Effectiveness Date
2024-06-20

Document Format Files

Seq Description Document Type Size
1 S-8 form_s-8_-_june_20_2024_.htm S-8 107689
2 EX-5.1 scyx-ex5_1.htm EX-5.1 16472
3 EX-23.1 scyx-ex23_1.htm EX-23.1 8216
4 EX-99.1 scyx-ex99_1.htm EX-99.1 269797
5 EX-99.2 scyx-ex99_2.htm EX-99.2 93965
6 EX-99.3 scyx-ex99_3.htm EX-99.3 47570
7 EX-FILING FEES scyx-exfiling_fees.htm EX-FILING FEES 33972
8 GRAPHIC img192767529_0.jpg GRAPHIC 3333
  Complete submission text file 0000950170-24-075319.txt   583451
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280328 | Film No.: 241054116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)